Acasti Pharma Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Acasti Pharma Inc.
CIK #0001444192
EDGAR Form CIK 2011 - 2025
10-K [0001444192]
10-Q [0001444192]
3 [0001444192]
4 [0001444192]
6-K [0001444192]
8-K [0001444192]
D [0001444192]
SC 13D [0001444192]
SC 13G [0001444192]
Form 13D/13G Filer Form 13D/13G Subject Filed
Nantahala Capital Management LLC Grace Therapeutics Inc [2025-05-15]
Adar1 Capital Management LLC Acasti Pharma Inc [2024-07-10]
Hirschman Orin Acasti Pharma Inc [2024-04-09]
Bank of America Corp /DE/ Acasti Pharma Inc [2024-02-13]
Peizer Terren S Acasti Pharma Inc [2019-07-19]
Haywood George Weaver Acasti Pharma Inc [2017-03-22]
Neptune Technologies & Bioressources Inc Acasti Pharma Inc [2013-12-18]
Form 3/4/5 Subject 2011 - 2025
Davis A Brian
Grace Therapeutics, Inc.
Neugeboren Edward
Kottayil George
Kavuru Vimal
DelAversano Robert J
Macdonald R. Loch
Kumar Amresh
D'Andrea Carrie
Kohli Prashant
ADAR1 Capital Management, LLC
ADAR1 Partners, LP
Olds Donald
Derby Michael
Canan John
D'Alvise Janelle
Lemieux Pierre
Ford Brian D.
Haseltine William A
Carter Roderick Noel
Rajitha Grace 2018 Irrevocable Trust
Iyer Swami Sambamurty
Boily Jean-Francois
Groch Brian J.
Terms | Privacy | Guide
tony@aum13f.com